1 Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, QLD, Australia.
2 Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia.
Aust N Z J Psychiatry. 2017 Sep;51(9):921-929. doi: 10.1177/0004867416681853. Epub 2016 Dec 21.
Having sufficient sera concentrations of 25-hydroxyvitamin D is important for a range of health outcomes including cardiometabolic diseases. Clinical studies in people with psychotic disorders suggest that a sizable proportion has suboptimal vitamin D status (i.e. vitamin D deficiency or insufficiency). Individuals with psychosis also have many of the risk factors associated with suboptimal vitamin D status such as smoking, obesity, and reduced physical activity. The aim of this study was to examine the prevalence and socio-demographic and clinical correlates of vitamin D status using a large, population-based sample of adults with psychotic disorders.
Data were collected as part of the Survey of High Impact Psychosis, a population-based survey of Australians aged 18-64 years with a psychotic disorder. 25-Hydroxyvitamin D concentration was measured in 463 participants. 25-Hydroxyvitamin D concentration was dichotomised into optimal (above 50 nmol/L) and suboptimal (below 50 nmol/L). The influence of a range of socio-demographic and clinical variables on vitamin D status was examined using logistic regression.
Nearly half (43.6%) of the participants had suboptimal vitamin D status. Those with (a) increased physical activity or (b) positive symptoms had significantly reduced odds of having suboptimal vitamin D status. However, there were no significant associations between suboptimal vitamin D status and other psychiatric symptom measures or cardiometabolic risk factors.
Many people with psychotic disorders have suboptimal vitamin D status. As part of the routine assessment of physical health status, clinicians should remain mindful of vitamin D status in this vulnerable population and encourage the use of appropriate vitamin D supplements.
25-羟维生素 D 具有足够的血清浓度对于包括心血管代谢疾病在内的一系列健康结果都很重要。对精神病患者的临床研究表明,相当一部分人的维生素 D 状态不佳(即维生素 D 缺乏或不足)。精神病患者也具有与维生素 D 状态不佳相关的许多风险因素,如吸烟、肥胖和体力活动减少。本研究旨在使用大量精神病患者的人群样本,检查维生素 D 状态的流行情况以及社会人口统计学和临床相关性。
数据是作为基于人群的精神病患者调查 Survey of High Impact Psychosis 的一部分收集的,该调查对象为年龄在 18-64 岁之间的澳大利亚精神病患者。共有 463 名参与者检测了 25-羟维生素 D 浓度。25-羟维生素 D 浓度被分为两个类别:最佳(高于 50 nmol/L)和不佳(低于 50 nmol/L)。使用逻辑回归检查了一系列社会人口统计学和临床变量对维生素 D 状态的影响。
近一半(43.6%)的参与者维生素 D 状态不佳。那些(a)增加体力活动或(b)出现阳性症状的人,其维生素 D 状态不佳的可能性显著降低。然而,维生素 D 状态不佳与其他精神症状测量或心血管代谢危险因素之间没有显著关联。
许多精神病患者的维生素 D 状态不佳。在评估身体健康状况时,临床医生应注意到这一弱势群体的维生素 D 状态,并鼓励适当使用维生素 D 补充剂。